| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRR25 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | DCTPP1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | TXNRD1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AKT1S1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PTPRJ | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | CD9 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | SCRT2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CHCHD5 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ROPN1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | KLF10 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
